CONMED Corp — Director's Dealing 2012

Jun 5, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2012-06-01

Reporting Person: Darling Joseph G (President ConMed Linvatec)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-06-01	Common Stock	M	1500	—	Acquired	2473	Direct
2012-06-01	Common Stock	F	397	$26.09	Disposed	2076	Direct
2012-06-01	Common Stock	M	800	—	Acquired	2876	Direct
2012-06-01	Common Stock	F	212	$26.09	Disposed	2664	Direct
2012-06-01	Common Stock	M	800	—	Acquired	3464	Direct
2012-06-01	Common Stock	F	212	$26.09	Disposed	3252	Direct
2012-06-01	Common Stock	M	800	—	Acquired	4052	Direct
2012-06-01	Common Stock	F	212	$26.09	Disposed	3840	Direct
2012-06-01	Common Stock	M	2100	—	Acquired	5940	Direct
2012-06-01	Common Stock	F	556	$26.09	Disposed	5384	Direct
2012-06-01	Common Stock	F	529	$26.09	Disposed	4855	Direct
2012-06-01	Common Stock	M	2000	—	Acquired	6855	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-06-01	Rsus (restricted Stock Units)	$0	M	1500	Disposed	2018-06-01	Common Stock (1500)	Direct
2012-06-01	Rsus (restricted Stock Units)	$0	M	800	Disposed	2019-06-01	Common Stock (800)	Direct
2012-06-01	Rsus (restricted Stock Units)	$0	M	800	Disposed	2020-06-01	Common Stock (800)	Direct
2012-06-01	Rsus (restricted Stock Units)	$0	M	800	Disposed	2021-06-01	Common Stock (800)	Direct
2012-06-01	Rsus (restricted Stock Units)	$0	M	2100	Disposed	2021-07-29	Common Stock (2100)	Direct
2012-06-01	Rsus (restricted Stock Units)	$0	A	4000	Acquired	2022-06-01	Common Stock (4000)	Direct
2012-06-01	Sars (Stock Appreciation Rights)	$26.09	A	10000	Acquired	2022-06-01	Common Stock (10000)	Direct
2012-06-01	PSUs (Performance Stock Units)	$0	A	10000	Acquired	2021-06-01	Common Stock (10000)	Direct
2012-06-01	PSUs (Performance Stock Units)	$0	M	2000	Disposed	2021-06-01	Common Stock (2000)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per
share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2006 Stock
Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year
after the grant date.

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.

F3: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs vesting over a seven year period with 14% of the RSU's vesting in the first through the fifth year starting June 1, 2012 and 15% vesting in the sixth and seventh year.

F4: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

F5: Each performance share unit (PSU) represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long- Term Incentive Plan, with the PSUs generally vesting over a five year period. The performance share units vest upon the achievement of performance goals.